Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geradts

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Archives of Pathology & Laboratory Medicine|August 25, 2001
Aberrant expression of tumor suppressor proteins in the Ewing family of tumorsA Maitra, H Roberts, A G Weinberg, et al.
Forensic Science International|May 12, 2001
Image matching algorithms for breech face marks and firing pins in a database of spent cartridge cases of firearmsZ J Geradts, J Bijhold, R Hermsen, et al.
Cancer|November 26, 1999
Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinomaP A Gehrig, L Van Le, B Olatidoye, et al.
Breast Cancer Research and Treatment|October 27, 2001
Tumor characteristics in African American and white womenH Furberg, R Millikan, L Dressler, et al.
Oncogene|June 14, 2011
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cellsX Cao, J Geradts, M W Dewhirst, et al.
Cancer Research|December 15, 1995
Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expressionJ Geradts, R A Kratzke, G A Niehans, et al.
British Journal of Cancer|March 29, 2000
Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological featuresJ Geradts, K M Fong, P V Zimmerman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodiesJ Geradts, R H Hruban, M Schutte, et al.
Cancer Research|April 1, 1986
Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumorJ Geradts, J Richards, M Edery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancersJ Geradts, K M Fong, P V Zimmerman, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Archives of Pathology & Laboratory Medicine|August 25, 2001
Aberrant expression of tumor suppressor proteins in the Ewing family of tumorsA Maitra, H Roberts, A G Weinberg, et al.
Forensic Science International|May 12, 2001
Image matching algorithms for breech face marks and firing pins in a database of spent cartridge cases of firearmsZ J Geradts, J Bijhold, R Hermsen, et al.
Cancer|November 26, 1999
Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinomaP A Gehrig, L Van Le, B Olatidoye, et al.
Breast Cancer Research and Treatment|October 27, 2001
Tumor characteristics in African American and white womenH Furberg, R Millikan, L Dressler, et al.
Oncogene|June 14, 2011
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cellsX Cao, J Geradts, M W Dewhirst, et al.
Cancer Research|December 15, 1995
Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expressionJ Geradts, R A Kratzke, G A Niehans, et al.
British Journal of Cancer|March 29, 2000
Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological featuresJ Geradts, K M Fong, P V Zimmerman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodiesJ Geradts, R H Hruban, M Schutte, et al.
Cancer Research|April 1, 1986
Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumorJ Geradts, J Richards, M Edery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancersJ Geradts, K M Fong, P V Zimmerman, et al.
Pageof 6